Delivery Order 36F79725D0146-36C24526N0596
Award Date 5/21/26
Potential Completion Date 5/22/26
Potential Value $23K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Carrollton, TX 75010, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Merck Sharp & Dohme LLC was awarded a delivery order valued at $22,508.03 for WELIREG (belzutifan) 40 mg under the Department of Veterans Affairs' Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB). The award is effective as of April 15, 2026, with an ultimate completion date of April 16, 2026, and will be performed in Carrollton, Texas. This delivery order was issued under firm fixed pricing with no set-aside designation and represents a continuation of Merck's role as a...
- The U.S. Department of Veterans Affairs (VA) awarded a firm-fixed-price delivery order contract to Merck Sharp & Dohme LLC, doing business as Merck, for the supply of the cancer drug Welireg (belzutifan). The $239,578.32 contract was awarded on February 1, 2025, with a completion date of January 31, 2026. This award is a part of Merck's larger Federal Supply Schedule (FSS) contract for pharmaceuticals and drugs. Merck, a major pharmaceutical manufacturer, has an extensive portfolio of...
- This federal contract award is for the delivery of Belzutifan (Welireg) 40 mg, a pharmaceutical product, to the U.S. Department of Veterans Affairs (VA). The contract was awarded to Merck Sharp & Dohme LLC, doing business as Merck, a major pharmaceutical manufacturer and supplier to the federal government. The contract is a Delivery Order under Merck's Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs. It has a firm fixed price of $19,964.86 and a completion date of...
- This is a firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 5 (VISN 5), a civilian agency, to Merck Sharp & Dohme LLC (doing business as Merck), a major pharmaceutical manufacturer. The contract is for the supply of Belzutifan (Welireg) 40 mg, a cancer drug. The contract has a ceiling value of $22,051.39 and a completion date of June 27, 2025. This contract award is not associated with a set-aside designation. Merck is a significant supplier to the...
- This federal contract award is for the pharmaceutical product "3 BTS WELIREG 40MG TAB" delivered by Merck Sharp & Dohme LLC, doing business as Merck, to the Veterans Integrated Service Network 20 (VISN 20), a civilian agency under the U.S. Department of Veterans Affairs. The firm fixed-price delivery order has a ceiling value of $66,154.17 and an ultimate completion date of December 31, 2025. The contract was awarded on October 20, 2025 and does not utilize any set-aside...
- This is a Delivery Order contract awarded by the Veterans Integrated Service Network 5 (VISN 5), a defense agency, to Merck Sharp & Dohme LLC (doing business as Merck), a major pharmaceutical manufacturer. The contract is for the delivery of the drug BELZUTIFAN (WELIREG) 40 MG, which is used for cancer treatment. The contract has a ceiling value of $19,964.86 and is a Firm Fixed Price contract type. The contract is not set aside for any specific business category. Merck is a large for-profit...
- Merck Sharp & Dohme LLC, doing business as Merck, has been awarded a $139,754.02 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20. The order is for the provision of Welireg to meet veteran patient needs through September 6, 2024. Welireg will be delivered to the place of performance in Carrollton, Texas under firm fixed price terms. No set-aside...
- This is a firm fixed-price delivery order awarded by the Veterans Integrated Service Network 5, a civilian agency under the Department of Veterans Affairs, to Insmed Inc. for the drug BELZUTIFAN (WELIREG) 40 MG. The contract has a ceiling value of $10,105.41 and a completion date of February 17, 2025. Insmed Inc. is a global biopharmaceutical company that provides pharmaceuticals and drugs to the VA, including the antibiotic amikacin and the drug ARIKAYCE for the treatment of nontuberculous...
- Merck Sharp & Dohme LLC (Merck) was awarded a delivery order valued at $336,622.94 on March 10, 2025, for emergency procurement of WINREVAIR (sotatercept-csrk), a pharmaceutical treatment for pulmonary hypertension. The delivery order is issued under Merck's parent Federal Supply Schedule contract (FSS-61-IB) for Pharmaceuticals and Drugs with the Department of Veterans Affairs, valued at $5.84 billion and extending through May 31, 2030. This non-competitive delivery order carries no...
- This is a firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 5 (VISN 5), a civilian agency, to Merck Sharp & Dohme LLC (Merck), a prominent pharmaceutical manufacturer. The contract, which does not have a set-aside designation, is for the drug WINREVAIR 45 MG with a ceiling value of $10,496.92 and a period of performance ending on September 17, 2025. Merck, a for-profit organization and manufacturer of goods, is a critical partner in supporting...